BLRX
BioLineRx Ltd.
Company Overview
| Mkt Cap | $13.69M | Price | $3.47 |
| Volume | 29.61K | Change | +0.58% |
| P/E Ratio | -1.5 | Open | $3.40 |
| Revenue | $22.9M | Prev Close | $3.45 |
| Net Income | $-9.2M | 52W Range | $2.30 - $22.40 |
| Div Yield | N/A | Target | $26.00 |
| Overall | 34 | Value | -- |
| Quality | 39 | Technical | 30 |
No chart data available
Stock Overview
Updated DailyBioLineRx Ltd. (BLRX) is a leading Healthcare company in the Biotechnology industry, currently trading at $3.47 with a market capitalization of $13.69 million. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating concerning quality fundamentals with a MarketXLS quality score of 39.
Today's trading session shows BLRX with a volume of 30K shares. The stock opened down 1.45% from yesterday's close of $3.45. Current analyst estimates project earnings of $-0.63 per share for this year, with next year targeting $NA.
BLRX demonstrates concerning technical signals based on technical analysis. The company trades on the NSC exchange and operates alongside industry peers including ORTH-CA, OTIC, OTLC, OTLK.
Key investment considerations for BLRX include concerning overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 649.3%. The stock shows neutral valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 07:29 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BLRX | $3.47 | +0.6% | 29.61K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |